Volume 11, Number 10—October 2005
Research
Vancomycin and Home Health Care
Thomas G. Fraser*1, Valentina Stosor*, Qiong Wang†, Anne Allen‡, and Teresa R. Zembower*
Table 3
Demographic and clinical characteristics of 296 patients referred for home infusions of vancomycin from December 1997 through May 2002*
| Characteristic | Use per guidelines, N = 180 | Use outside guidelines, N = 116 | p value† |
|---|---|---|---|
| Mean age, years (range) | 53.6 (19–90) | 48.9 (19–86) | 0.016 |
| Male, no. (%) | 109 (60.6) | 76 (65.5) | 0.389 |
| Ethnicity, no. (%) | |||
| Caucasian | 100 (55.6) | 75 (64.7) | 0.120 |
| African-American | 52 (28.9) | 22 (19.0) | 0.054 |
| Asian | 3 (1.7) | 0 | 0.283 |
| Hispanic | 7 (3.9) | 2 (1.7) | 0.490 |
| Other | 18 (10.0) | 15 (12.9) | 0.434 |
| Mean length of stay, days (range) | 12.2 (2–52) | 9.5 (2–67) | 0.007 |
| Coexisting conditions, no. (%) | |||
| Diabetes mellitus | 47 (26.1) | 28 (24.1) | 0.703 |
| Malignancy | 39 (21.7) | 12 (10.3) | 0.012 |
| Spinal cord injury | 28 (15.6) | 13 (11.2) | 0.290 |
| Decubitus ulcer | 31 (17.2) | 11 (9.5) | 0.063 |
| Acute renal failure | 15 (8.3) | 6 (5.2) | 0.301 |
| ESRD | 5 (2.8) | 1 (0.9) | 0.409 |
| Immunocompromised status | 10 (5.6) | 8 (6.9) | 0.637 |
| HIV | 3 (1.7) | 1 (0.9) | 1.000 |
| Charlson score, mean (range) | 1.4 (0–8) | 1.1 (0–14) | 0.217 |
| Insurance status, no. (%) | 176 (97.8) | 116 (100) | 0.158 |
| Private | 121 (67.2) | 86 (74.1) | 0.205 |
| Medicare | 74 (41.1) | 36 (31.0) | 0.080 |
| Medicaid | 48 (26.7) | 25 (21.6) | 0.319 |
| Discharging service, no. (%) | |||
| Medical | 108 (60.0) | 44 (37.9) | <0.001 |
| General medicine | 66 (36.7) | 29 (25.0) | 0.036 |
| Medicine subspecialties | 29 (16.1) | 10 (8.6) | 0.063 |
| Hematology/oncology | 13 (7.2) | 5 (4.3) | 0.306 |
| Surgical | 67 (37.2) | 69 (59.5) | <0.001 |
| General surgery | 2 (1.1) | 4 (3.5) | 0.215 |
| Transplant surgery | 5 (2.8) | 6 (5.2) | 0.350 |
| Vascular surgery | 14 (7.8) | 7 (6.0) | 0.569 |
| Orthopedics/neurosurgery | 31 (17.2) | 41 (35.3) | <0.001 |
| Other surgical subspecialties | 15 (8.3) | 11 (9.5) | 0.733 |
| Other hospital services | 5 (2.8) | 3 (2.6) | 1.000 |
| Consultation by infectious diseases, no. (%) | 85 (47.2) | 58 (50.0) | 0.641 |
*ESRD, end-stage renal disease requiring dialysis; immunocompromised status, immunocompromised from causes other than HIV.
†Values <0.05 were considered significant.
1Current affiliation: Cleveland Clinic Foundation, Cleveland, Ohio, USA
Page created: February 22, 2012
Page updated: February 22, 2012
Page reviewed: February 22, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.